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ABSTRACT 
 
A Novel Method for Synthesis of Hydroxytyrosol 
by 
Emmanuel Onobun 
Hydroxytyrosol, 3,4-dihydroxyphenolethanol, a naturally occurring polyphenol most common in 
olive tree (Olea europaea), is one of the most effective member of the polyphenols family, 
because of its remarkable antioxidant activity, its ability to inhibit oxidation of low density lipids 
(LDL), and its protection against DNA oxidative damage. Hydroxytyrosol, which is widely used 
in cosmetics and food supplements industries, can be purchased as an olive oil extract that 
contains low concentration of hydroxytyrosol besides other polyphenols. The price and low 
natural abundance of hydroxytyrosol make alternative synthetic sources very attractive.  In this 
research, a novel method for the synthesis of pure hydroxytyrosol from a commercially 
inexpensive precursor catechol was developed; this can satisfy the increasing market demand and 
provide a more economical alternative source for this valuable polyphenol. 
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CHAPTER 1 
INTRODUCTION 
 
Recently, there has been increasing interest in polyphenols research, primarily due to 
their wide range of biological activities. Structurally, polyphenols are composed of two or more 
phenolic rings. The unique chemical structure of polyphenols is believed to be the main factor 
for their activities as antioxidants, and free radical scavenges. The antioxidant activities of 
polyphenols are affected by factors such as the number of hydroxyl groups in the phenol, nature 
of the compound to be reduced, and the degree of methoxylation.1 
The Mediterranean basin has the lowest overall occurrence of cancer in relations to other 
parts of the world 2. Research on animals and in vitro studies together with an enormous body of 
epidemiological statistics3 has linked that to the dietary lifestyle in such countries, which 
involves foodstuff rich in vitamins and polyphenols such as whole grain bread and cereal, fruits 
and vegetables, fish, and olive oil.4 Lately there has been  increasing focus on products from 
Olea europaea L. (olive), principally olive leaves  as a source of a potent polyphenol called 
hydroxytyrosol (1).2 Although hydroxytyrosol is available commercially as olive leaves extract, 
the low concentration of the active ingredient, coupled with its high cost and low natural 
abundance has made an alternative synthetic route of hydroxytyrosol very attractive. 
The main purpose of this work is to explore new methods for the synthesis of pure 
hydroxytyrosol from readily available and relatively inexpensive precursors such as catechol. 
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Polyphenols 
There are over four thousand phenolic phytochemicals widely distributed in the plant 
kingdom. Dietary phenolic compounds are of three major classes, namely polyphenols, 
flavonoids and phenolic acids.5,6 Polyphenols are produced in plants as secondary metabolites to 
protect plants from ultraviolet radiation and pathogens.7  According to recent findings, 
polyphenols play a major role in the prevention of degenerative diseases, including cancers, 
cardiovascular and neurodegenerative diseases.8,9 Furthermore, being a strong antioxidant, 
polyphenols increase the antioxidant activities of vitamins and enzymes in combating oxidative 
stress that is triggered by excess reactive oxygen species (ROS).10  The detailed mechanisms of 
biological activities of some polyphenols are not well understood.11  
The hydroxyl group of the phenolic compound is bonded to a benzene ring. This makes 
phenolic compounds more reactive and more acidic than alcohols; this enables them also to form 
stable phenoxy radicals.1 This characteristic of polyphenols makes them good reducing agents by 
donating hydrogen atoms to ROS, thereby acting as an antioxidant by inhibiting harmful 
chemical processes involving ROS, such as lipid oxidation and DNA damage.  
Besides their strong antioxidant properties, polyphenols have other important biological 
activities. Reports have shown that polyphenols play a role in the prevention of degenerative 
diseases such as cancers, diabetes mellitus, and neurodegenerative diseases.12 Polyphenols have 
been implicated in other biological activities such as antibacterial,13 antiviral,14 anti-histamine15 
and anti-inflammatory properties.16 Several authors12,17,18 have reviewed epidemiological 
evidence suggesting the role of dietary polyphenol in prevention of cardiovascular diseases 
15 
 
Polyphenols such as hydroxytyrosol and oleuropein19 with two adjacent hydroxyl groups on a 
benzene ring,20 are more potent antioxidants than polyphenols with one hydroxyl group per 
benzene ring.21,22 
Hydroxytyrosol 
Hydroxytyrosol or 3,4-dihydroxyphenolethanol was first identified as a component of 
echinacoside, a phenolic glycoside containing one glucose and two rhamnose moieties, linked to 
both a dihydroxyphenylethanol residue and caffeic acid.  Hydroxytyrosol showed antibiotic 
activity against Staphylococcus aureus, bacteria obtained from the roots of Echinacea 
angustifolia. 26,27  
                
         Hydroxytyrosol          Echinacoside 
 
It is one of the main bioactive polyphenolic compounds found in small amounts in virgin 
olive oil,23,30 but in higher amounts in olive oil mill wastewater.24 Hydroxytyrosol is produced 
during the hydrolysis of glycoside oleuropein catalyzed by cellular esterases during olive 
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processing and storage. Similar hydrolysis takes place also during the debittering process under 
basic conditions28,29 
Hydroxytyrosol is a phenylethanoid composed of a catechol moiety and a phenethyl 
alcohol substituent. Catechol has a lower O−H bond dissociation enthalpy (77.7−80.1 kcal/mol) 
when compared to phenol (85.1−88.0 kcal/mol).31 Thus the catechol moiety is capable of 
stabilizing free radicals via the creation of intramolecular hydrogen bonds32.  
 
Free Radicals 
During certain chemical reactions, weak bonds split in such a way that allows an atom, 
molecule or ion to have odd, unpaired electron. These species are called radicals or free radicals. 
.33 Having unpaired electrons, free radicals tend to be highly unstable and react readily with other 
compounds where they act as oxidants or reductants.34 Free radicals can gain electrons from a 
stable molecule and generate new free radicals. This starts a series of reactions which may 
eventually lead to damaging living cells. 
Free radicals are generated either during metabolic processes by actions of the immune 
system to neutralize bacteria and viruses or through external sources including exposure to x-ray, 
air pollutions, industrial chemicals, or tobacco.34,35 Free radicals can be formed from enzymatic 
reactions, such as those involved in phagocytosis, the respiratory chain, cytochrome p-450 
system, and in the prostaglandin synthesis;34,35 they can also be formed in non-enzymatic 
reactions such as reactions between oxygen and organic compounds, and in reactions involving 
ionization.34 Among the major oxygen-containing free radicals implicated in many diseases are 
hydrogen peroxide (H2O2), superoxide anion radical (O2
• −), peroxynitrite  (ONOO−), 
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hypochlorite (NaClO), singlet oxygen (1O2), hydroxyl radical (
•OH), and nitric oxide (NO). High 
concentration of free radicals in the body is harmful.  Free radicals target and damage the main 
components of the cell including cell membrane, nucleic acids, and proteins.  The damage, 
particularly those done on the nucleic acid, may lead to the development of degenerative diseases 
such as cancer.  
The most prevalent types of free radicals generated in living systems are those that 
contain reactive oxygen elements, called reactive oxygen species (ROS).36 The unique electronic 
configuration of molecular oxygen makes it a free radical. Furthermore, superoxide anion 
radicals (O2
• −) are formed when an additional electron is added to molecular oxygen.37,38 
Superoxide anions, which are generated in metabolic processes or from activation of oxygen by 
physical irradiation, are recognized as the primary ROS’s. These primary ROS’s can further 
react with other molecules giving rise to secondary ROS’s; this occurs enzymatically or in metal-
catalyzed processes.39 The superoxide, which has been linked pathophysiologically to some 
diseases,41,42 is found mainly in the mitochondria;40 it is produced during the energy transduction 
process when there is a premature leak of electrons to oxygen. Hydroxyl radical (HO•) is also 
highly reactive and harmful; it has a very short half-life in vivo (10-9 s).37,43 Molecular oxygen is 
an oxidant, and in the presence of [4Fe–4S] cluster-containing enzymes and under oxidative 
stress it promotes the production of hydroxyl radicals from hydrogen peroxide.39, 115 
 
Oxidative Stress 
The concept of oxidative stress first surfaced in the 1950s in the study of free radicals, the 
toxic effects of both ionizing radiation and of molecular oxygen,44 and how they can contribute 
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to the phenomenon of aging.45 However, it was not until the 1970s that use of the term oxidative 
stress became frequent.45 The slow acceptance of free radicals in biology can be attributed to 
some factors such as the short life of free radicals, the lack of experimental tools for their study 
and the theoretical and hypothetical nature of its beginnings.46 In general, the term oxidative 
stress is used to define the steady state level of oxidative damage in a cell, tissue, or organ, 
brought about by the ROS. The imbalance between free radical generation and antioxidant 
defenses that bring about oxidative stress has been implicated in a wide range of damages to 
molecular species including proteins, nucleic acids, and lipids.48 Tissues injured as a result of 
short-term oxidative stress may increase the activities of radical generating enzymes (e.g. 
cyclooxygenase, lipogenase), increase production of free iron, copper ions, increase activation of 
phagocytes, or cause a disruption in the electron transport chain of oxidative phosphorylation, 
leading to the production of excess ROS.33 Oxidative stress is assumed to play a role in 
inflammatory condition, certain cancers, the process of aging and anthersclerosis. Furthermore, it 
is thought to significantly contribute to all inflammatory diseases.43 Changes in the structure and 
function of lipids and proteins also have linkage to oxidative stress.33  
A Recent study of mutation suggests that persistent oxidative stress participates in 
carcinogenesis.50 The increased occurrence of gastric cancer and colorectal cancer has been 
linked to persistent gastritis and ulcerative colitis respectively.51,52 There are three main stages of 
cancer development process including initiation, promotion, and progression. During the 
initiation, there is an inheritable mutation in the cells caused by interaction a chemical with the 
DNA.53 ROS is thought to have multiple effects in this stage by facilitating carcinogen activation 
through hydroxyperoxide-dependent oxidation mediated by peroxyl radicals,54 causing damage 
to the DNA and preventing its repair. ROS is also thought to play a crucial role in the clonal 
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expansion of initiated cell during the promotion stage.54 Oxidative stress is believed to be directly 
linked to the development of cancer characteristics including chemotherapy resistance, invasion, 
metastasis, uncontrolled growth and genomic instability.54 However, direct scavenging of ROS 
by antioxidants and inhibition of cell proliferation secondary to the protein phosphorylation can 
reduce carcinogenesis induced by oxidative stress.33  
The aging phenomenon is the accumulated result of oxidative damage to the cells and 
tissues derived mainly from aerobic metabolism.55 Pathological changes linked to aging is 
thought to originate from free radical damage to cells. 33,56 The main processes of aging are 
associated with DNA or the buildup of cellular and functional damage.57 Research suggest that 
controlling the amount of free radical damage by increasing the antioxidant defense can 
significantly delay aging and prolong life.33 The optimal intake of nutritional antioxidants may 
significantly reduce oxidative damage related to free radical. 
 
Prevention of DNA Damage by Polyphenols 
It is well established that endogenous reactive oxygen species originates from normal 
cellular processes (usually non-pathogenic), and these cellular processes account for the 
background levels of oxidative DNA damage observed in normal tissue.123 These reactive species 
may also be generated by ionizing or ultraviolet radiation, as well as cell metabolism of certain 
exogenous chemicals that may produce electrons which can be transferred to molecular oxygen 
generating superoxide (O2
• – ). Hydroxyl radicals is also produced by redox-active metal ions 
such as Fe2+ and Cu+ in the presence of hydrogen peroxide, a byproduct of respiration.126  
20 
 
It is reported that oxidative DNA damage by •OH, mediated by iron, is the main cause of 
cell death given oxidative stress conditions in both prokaryotes and eukaryotes, including 
humans.127-129  Reports suggests that Cu+ can produce DNA-damaging •OH sixty times faster than 
Fe2+.130 Reactive oxygen species may react with cellular biomolecules, such as DNA, leading to 
modification and potentially serious consequences for the cell regardless of their origin. 123 For 
instance, the highly reactive •OH may modify DNA either by addition to double bonds of DNA 
bases or by abstraction of an H atom from the methyl group of thymine and each of the C-H 
bonds of 2ʹ-deoxyribose.124  
Certain polyphenols can inhibit oxidizing chain reactions in a number of ways, including 
direct quenching of reactive oxygen species, inhibition of enzymes, and chelation of metal ions 
(Fe3+, Cu+).125 The metal-mediated DNA damage inhibition is directly linked to the metal-
binding nature of these polyphenols. Once bound to iron or copper, the polyphenol greatly shift 
iron oxidation potentials and stabilize Fe3+ over Fe2+ and Cu2+ over Cu+, a component that may 
inhibit metal redox cycle.131 
 
Antioxidant Activity 
Usually, the body can effectively manage free radicals generated, but if there are no 
antioxidants or if there is excessive production of free radical, damage may arise.58 The phenolic 
compounds of Olea europaea L. have been studied extensively mainly because of its antioxidant 
property. Hydroxytyrosol, which is one of the major phenolic compound found in Olea europaea 
L., has especially received much attention due to its strong antioxidant activity.58 Hydroxytyrosol 
owes its strong antioxidant capability, associated with the presence of the ortho-dihydroxyphenyl 
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moiety, to its capacity for free radical scavenging during oxidation processes and its reducing 
power on Fe3+.59,60 Research suggest that the strength of antioxidant activity by these phenolic 
compounds correlates to the number of hydroxyl substitutions.22 In particularly, phenolic 
compounds having ortho-dihydroxy substituents confers a high antioxidant ability, while those 
with a mono-hydroxyl substituent on the benzene ring, such as tyrosol, have no activity. The 
ortho-diphenols act as an antioxidant by forming intramolecular hydrogen bond linking the 
hydrogen of the hydroxyl group with the phenoxy radical thus, improving the stability of the 
radical.19 Hence, the catechol disrupts the chain propagation by donating radical hydrogen to 
alkylperoxyl radicals generated amid the initiation stage of lipid oxidation (scheme 1).61 The 
hydroxytyrosol quinone product formed can either undergo Michael addition reaction with 
glutathione to give a glutathione conjugate or it be recycled in a redox reaction involving 
ascorbate to give hydroxytyrosol.122 Studies on biological activities of hydroxytyrosol have 
shown its’ potent free radical scavenging actions against superoxide radical;19 its’ defense 
against DNA damage induced by peroxynitrite, produced by reaction between superoxide radical 
anion (O2
• −) and nitric oxide (NO); its’ efficiency against oxidative stress caused by tert-
butylhydroperoxide on human hepatoma HepG2 cells62 or by free radicals associated with 
neurodegenerative or other cerebral diseases.63,64  
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Scheme 1: Free radical scavenging by hydroxytyrosol 
Free radicals also trigger the oxidation of low-density lipoproteins (LDLs) which is a 
lipid peroxidation chain reaction. Hydroxytyrosol is known to prevent LDL oxidation occurring 
in the body owing to its capability for scavenging peroxyl radicals.65,66 This olive polyphenol 
also decreases the oxidation of the low-density lipoproteins carrying cholesterol (LDL-C), which 
is a crucial step in the advancement of cardiovascular diseases including antherosclerosis,67 and 
prevents cell activities associated with physiopathological processes, including thrombogenic 
events, with platelet inhibitory capability similar in magnitude to aspirin.68,69 Using metal-
independent oxidative systems and stable free radicals, like 1,1-diphenyl-2-picryl-hydrazyl 
(DPPH), the antioxidant activities of hydroxytyrosol was proven to be more efficient when 
compared with butylated hydroxytoluene (BHT) or vitamin E70,66 and strongly impede copper 
sulfate-induced oxidation of LDL in a dose-dependent manner at various concentrations.70,71 
Manna et al., in 1997 demonstrated, using a model of oxidative stress induced in intestinal 
epithelial cells, the antioxidant property of hydroxytyrosol.72 These same authors reported the 
protective effect of hydroxytyrosol against hydrogen peroxide-induced damage on human 
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erythrocytes in a later publication.73 Deiana et al., in 1999 indicated that low concentration of 
hydroxytyrosol (50 µM) is highly potent in scavenging peroxynitrite (NO3
-) and hence protective 
against the peroxynitrite-dependent nitration of tyrosine and peroxynitrite-induced DNA 
damage.74  
Anticancer Activity 
Cancer has significantly impacted the society in the United States and across the globe.116 
In 2015, the National Center for Health Statistics ranked cancer as the second leading cause of 
death in the United States. 116 Over the past two decades, scientists have continuously sort ways 
to prevent or remedy this deadly disease. Studies have shown an inverse relationship between 
consumption of fruits and vegetables, and development of different kinds of cancer.75,76 A fit 
lifestyle including ideal nutrition, could be prevented in more than two third of human cancers.77 
Presently, the area of cancer chemoprevention is one with enormous potential in the prevention 
of cancer.80 Chemoprevention involves the use of synthetic, natural or biologic chemical agents 
to suppress, reverse or inhibit the progression of invasive cancer either through blocking the 
DNA damage that initiates carcinogenesis or by restraining or reversal of the progression of 
premalignant cells in which those DNA damage has already occurred.78,79 The chemoprevention 
by dietary polyphenols is gaining more grounds due to their capacity to interfere with multiple 
signaling pathways, in various types of cancer, by targeting a plethora of cellular molecules and 
molecular pathways.81 Given cancer chemopreventive activities, research has shown that 
hydroxytyrosol prevents DNA damage caused by various genotoxic molecules thereby hindering 
the initiation of carcinogenesis.82 Furthermore, hydroxytyrosol prevents the proliferation and 
inducing apoptosis in various tumors cell lines and in doing so help to prevent the 
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promotion/progression stage of carcinogenesis.83 Much awareness has been given to 
hydroxytyrosol as the chief anti-cancer compound in several in vitro studies, using human 
carcinoma cells, which shows notable effects in many cancer cell lines, either solitary or in 
association.84  
 
Cardiovascular Protection 
Recent reports have established the benefits of olive oil phenolic compounds (like 
oleuropein and hydroxytyrosol) on protection against cardiovascular diseases.97-101 The 
protective action of oleuropein (OL) and hydroxytyrosol (HT) against antherosclerosis was 
highlighted using prechemical experimental models. 101-105 These compounds have also shown 
inhibition to copper sulfate-induced oxidation of low-density lipoprotein (LDL).101-105 Jemai et 
al. in their study revealed the beneficial effects of these phenolic compounds in promoting 
hypocholesterolemia by lowering LDL plasma levels and the overall cholesterol level. Similarly, 
the expression of the proteins associated with aging was found to have reduced after the 
treatment of cardiomyocytes from rats with hydroxytyrosol.106 
 
Antidiabetic Activity 
A recent report by the World Health Organization (WHO) shows that the number of 
people with diabetes has risen from 108 million in 1980 to 422 million in 2014 and that 8.5 % of 
adults over 18 years had diabetes.116 Diabetes is a chronic metabolic disease that eventually 
affects vital body organs in the long run. It occurs in cases where there is insufficient insulin 
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produced by the pancreas or when the body is unable to utilize the insulin produced 
adequately.117  Reports suggested that oxidative stress is a possible contributor to the 
pathogenesis of the various issues associated with the disease.107,108 It has also been proposed 
that hypoglycemia causes oxidative stress, which is conclusive from the features of diabetes 
which include the altering of glutathione redox state, decrease of individual naturally occurring 
antioxidants, lipid peroxidation and a decrease in the activity of the antioxidant enzyme.109-111 
Natural antioxidants have been highlighted as a possible means of combating oxidative damage 
in diabetes, as studies have also suggested that some dietary antioxidants (like vitamins and 
flavonoids) help to reduce the effects of oxidative stress.112 The fruits, leaves, and oils of the 
olive tree have been identified to have the highest antioxidant activity. The olive tree contains 
well-known antioxidants which include oleuropein and hydroxytyrosol among others.113 
Previous studies have also highlighted the antihyperglycemic effects of oleuropein on diabetic 
rats. Jemai et al. (2009) demonstrated the promising effects of hydroxytyrosol and oleuropein in 
combating the effects of oxidative stress in diabetic rats, concluding that they have beneficial 
hypoglycemic effects suitable for managing diabetes.114  
 
Synthesis of Hydroxytyrosol 
Hydroxytyrosol is naturally available as an extract from extra virgin olive oil. However, 
the insufficiency of this natural source to meet demand has necessitated the need for synthetic 
methods of production. Various researchers have reported different methods employed in the 
synthesis of hydroxytyrosol. One of such methods is based on reduction of 3,4-dihydroxyphenyl 
acetic acid with Lithium aluminum hydride.85,86 Although this method is more convenient than 
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the extraction and purification of hydroxytyrosol, from wastewater generated by olive oil mills,87 
it utilizes an expensive and not readily available precursor. 
 
 
 
Scheme 2: Lithium aluminum hydride reduction of 3,4-dihydroxyphenyl acetic acid. 
 
Denis et al., synthesized hydroxytyrosol using eugenol (4-allyl-2- methoxyphenol), a 
commercially available major constituent of clove oil 88, as a precursor. This procedure involved 
conversion of eugenol to ozonide intermediate which upon reduction produces homovanillyl 
alcohol (4,4-hydroxy-3-methoxyphenethanol).89 This is followed by demethylation by sodium 
periodate (NaIO4) and reduction (Scheme 3).      
  
 
Scheme 3: Synthesis of 4, 4-hydroxy-3-methoxyphenethanol from eugenol and demethylation 
      process of homovanillyl in ethyl acetate. 32  
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Some other researchers have used biocatalyst in the synthesis of hydroxytyrosol. One of 
such methods involves tyrosinase-catalyzed process, excess vitamin C, and tyrosol as a 
precursor, (Scheme 4).86 The enzyme catalyzes hydroxylation and oxidation of tyrosine.  
 
 
 
Scheme 4: Synthesis of hydroxytyrosol from tyrosol precursor in the presence of both mushroom 
       tyrosinase and Ascorbic Acid.86 
 
 
Roberta et al. synthesized hydroxytyrosol from tyrosol, but only after protection of the 
alcohol hydroxyl group first (scheme 5) by dimethylcarbonate. Oxidation by 2-iodoxybenzoic 
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acid or Dess-Martin periodinase, followed by reduction with sodium dithionite, then deprotection 
afforded hydroxyltyrosol.90 
 
 
Scheme 5: Synthesis of hydroxytyrosol from tyrosol.90 
 
Research Objectives 
Hydroxytyrosol is currently being produced by extraction from natural sources or by 
synthetic methods. Different procedures have been optimized to isolate hydroxytyrosol from 
olive oil waste waters.85 Such methods resulted in isolation of hydroxytyrosol in low 
concentration, and often in combination with other polyphenols. Several methods for the 
synthesis of hydroxytyrosol have been described in literature, but they include many steps and 
use expensive starting materials and some were of low yields.86,91,92 Hydroxytyrosol is being sold 
by chemical companies although at a very high price.  
Considering the industrial utilization of hydroxytyrosol, together with increasing studies of its 
biological properties, it is imperative to have more convenient and efficient methods to prepare 
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this polyphenol. The main objective of this research is to develop a novel method for the 
synthesis of hydroxytyrosol from relatively inexpensive precursors such as catechol, to provide 
more economic synthetic alternative routes.  
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CHAPTER 2 
EXPERIMENTAL 
Materials and General Methods 
The precursor (catechol), as well as reagents and solvents listed for all reactions, were 
obtained from commercial sources. All chemical reagents and solvent listed were used without 
further purification unless otherwise stated. Some reagents used in this research include:  
Catechol, acetyl chloride, lead tetraacetate, boron trifluoride etherate, 1,2 dibromoethane, 
bromoethanol, trimethylsilyl chloride, triethylamine, tert-butyldimethylsilyl chloride, Imidazole, 
lithium aluminium hydride, ethyl acetate, dichloromethane, tetrahydrofuran, silica gel,benzene, 
aluminium chloride, chloroacetyl chloride,petroleum ether, hexane, liquid bromine, and sodium 
hydroxide. 
The synthesized compounds were characterized by NMR spectroscopy. The NMR 
spectra were recorded on a JEOL-NMR Eclipse-400 MHz spectrophotometer. The chemical 
shifts of different peaks are quoted in parts per million (ppm) using the high-frequency position 
conversion, and the coupling constants value (J) are reported in Hz. The splitting patterns of 
resonance were also described as follows: singlet (s), doublet (d), doublet of doublet (dd), 
doublet of doublet of doublet (ddd), triplet (t), doublet of triplets (dt), td = triplet of doublets, 
quartet (q), and multiplet (m). The melting points of synthesized compounds were measured 
without calibration of the Cambridge Melt-Temp device. Purification of compounds by 
chromatographic and recrystallization techniques so as to obtain the pure form of synthesized 
compounds. 
31 
 
Experimental Procedures 
Synthesis of 3,4-dihydroxyacetophenone (3) 
 A Flask containing a suspension of aluminum chloride (0.98 g, 7.4 mmol) in 4 mL 1,2-
dibromoethane at 100C was stirred for 30 minutes. Powdered catechol (0.32 g, 2.9 mmol) was 
then added to the reaction mixture in three portions over 4 minutes.The reaction was further 
stirred at 100C for 30 minutes after which acetyl chloride (0.26 mL, 3.2 mmol) in 0.5 mL 
dibromoethane was added dropwise. The reaction mixture was allowed to warm to room 
temperature and stirred for an additional 20 hrs. After the reaction was complete, the mixture 
was set on ice and cooled to about 6 0C before quenching with 1M HCl (10 mL). The mixture 
was stirred for two hrs and thereafter diluted with CH2Cl2 (20 mL), and the organic layer was 
separated. The aqueous layer was extracted with EtOAc (4x20 mL), and the combined organic 
layer was washed with saturated sodium chloride (30 mL) and dried over anhydrous sodium 
sulfate. Evaporation of the solvent in vacuo gave 7 as a reddish solid (0.43 g, 97%). 
1H-NMR (400 MHz, CHLOROFORM-D) δ 7.42-7.28 (m, 2H), 6.80 (dd, J = 7.7, 0.7 Hz, 
1H), 2.46 (s, 3H). 
 
Synthesis of 3,4-diacetoxyacetophenone (4) 
To a round-bottom flask containing 6 g (45 mmol) of aluminum chloride in 20 mL 
dichloromethane, set in an ice bath, was added dropwise6.49 mL (91 mmol) of acetyl chloride in 
20 mL dichloromethane. Catechol, 2.00 g (18.2 mmol), was then added to the mixture within a 
period of five minutes. The mixture was then allowed to warm to room temperature and under 
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nitrogen atmosphere for seventy-two hours. The resulting solution was poured with mixing into 
40 g ice containing 20 mL concentrated hydrochloric acid.  The aqueous solution was repeatedly 
extracted with dichloromethane (3x60 mL). The combined organic layer was washed with 20 mL 
saturated sodium bicarbonate. After evaporation of the solvent, the product was purified by 
recrystallization from 1:3 dichloromethane/hexane (v/v) to give 3.39 g (79 %) of the desired 
product. 1H-NMR (CDCl3): δ 7.89-7.83 (dd,1H), 7.83-7.76 (d,1H), 7.34-7.28 (d,1H), 2.61-2.56 
(s,3H), 2.34-2.30 (d,6H).  13C-NMR: δ 196.08 (C=O), 168.20 (ROC=O), 168.84 (ROC=O), 
146.10 (ArC), 142.31 (ArC), 135.68 (ArC), 126.99 (ArC), 123.81 (ArC), 108.96 (ArC), 26.69 
(CH3), 20.80-20.70 (CH3) 
 
Synthesis of Methyl (3,4-diacetoxyphenyl)acetate (5) 
A mixture of 0.10 g (0.42 mmol) of 3,4-diacetoxyacetophenone, 0.088g (2.75 mmol) 
methanol, 0.24g (1.67 mmol) boron trifluoride etherate (BF3.Et2O) was added in one portion to a 
suspension of 0.198g (0.45 mmol) of lead tetraacetate in 1.11 mL of benzene. The reaction 
mixture was stirred at room temperature for 5h, after which the reaction was quenched by adding 
5mL cold water. The mixture was then extracted 3 times with ethyl acetate (3x10 mL). The 
combined organic layer was washed with saturated NaHCO3 until the pH is around 7, followed 
by a second wash with an equal volume of saturated NaCl, and the organic layer was dried over 
anhydrous sodium sulfate. After evaporation of solvent, 0.102 g of a dark brown viscous oily 
crude product was obtained. Further purified by column chromatography (dichloromethane/ethyl 
acetate 3: 1, v/v) gave a yellow viscous oily liquid (86 % yield).  1H-NMR (CDCl3): δ 7.18-7.07 
(m, 3H), 3.70-3.63 (s,3H), 3.63-3.55 (s,2H), 2.28-2.22 (s, 6H).   13C-NMR: δ 171.35 (ROC=O), 
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168.39 (ROC=O), 168.32 (ROC=O), 142.01 (ArC), 141.25 (ArC), 132.71 (ArC), 127.61 (ArC), 
124.41 (ArC), 123.50 (ArC), 52.29 (CH3), 40.48 (CH2), 20.74 (CH3). 
 
Synthesis of Hydroxytyrosol (1) 
LiAlH4 (0.083 g, 2.18 mmol) was suspended in 10 mL of dry tetrahydrofuran at room 
temperature. A solution of crude methyl (3,4-diacetoxyphenyl)acetate (0.096 g, 0.36 mmol) in 1 
mL of dry tetrahydrofuran was added dropwise.  Once addition was complete, the reaction 
mixture was refluxed for 3 hours, after which the mixture was cooled and treated with 10 mL of 
ethyl acetate containing  1.5 mL water, the mixture was concentrated under reduced pressure. 
The white residue was suspended in 10 mL of water and acidified to pH 2-3 with 6 M HCl. The 
mixture was extracted six times with ethyl acetate(6x 7 mL). The combined organic phase was 
washed with saturated sodium bicarbonate to pH 7.0–7.5. The combined aqueous phase was then 
extracted three times with ethyl acetate (3x 7 mL). The combined organic layer was dried over 
sodium sulfate and the solvent was evaporated under reduced pressure to give 0.065 g of the 
crude product. The crude product was purified on a silica gel column (dichloromethane/ethyl 
acetate 3: 1, v/v; 1: 3, v/v) to yield 0.049g (87 %) of the hydroxytyrosol as a light yellow oil. 1H-
NMR (CDCl3): δ 6.76-6.67 (d, 1H), 6.67-6.62 (s, 1H), 6.56-6.47 (d, 1H), 3.82-3.65 (t, 2H), 2.69-
2.55 (t, 2H).  13C-NMR:  δ 130.64 (ArC), 120.61 (ArC), 115.89 (ArC), 115.18 (ArC), 109.04 
(ArC), 63.57 (CH2), 38.35 (CH2). 
 
 
 
34 
 
Synthesis of (2-bromoethoxy)trimethylsilane (9) 
To a solution of 1 mL of bromoethanol and 4 mL of triethylamine (2 eq) in 3 mL THF 
stirred at 0 0C under a nitrogen atmosphere, was added dropwise 2.6 mL (1.5 eq) 
trimethylsilylchloride. The mixture was allowed to warm up to room temperature and stirred for 
eight hours. 3 mL of saturated ammonium chloride was then added to the reaction mixture and 
the resulting precipitate was filtered. The filtrate was then distilled and the product (a colorless 
liquid) collected in the range 125 0C – 135 0C with 84 % yield.   1H-NMR (CDCl3): δ 4.03-3.69 
(t, 2H), 3.51-3.27 (t, 2H), 0.25--0.06 (s, 9H).  
 
Synthesis of 1,2-bis-(trimethylsilyloxy)benzene (10) 
In a round-bottom flask, 1 g of catechol was dissolved in 6 mL of dry THF containing 5 
mL of triethylamine (4 eq), the solution was cooled in ice and under a nitrogen atmosphere. 
Trimethylsilyl chloride (3.45 mL, 3 eq) was added dropwise. The mixture was allowed to warm 
to room temperature and stirred for eight hours. 5 mL of saturated ammonium chloride was then 
added and the precipitate was filtered. The filtrate was then concentrated, and the product was 
purified using flash column chromatography (silica gel, solvent) to yield 2.04 g of a colorless 
liquid (79 %). 1H-NMR (CDCl3): δ 6.99-6.78 (m, 4H), 0.41-0.22 (m, 18H).  
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Synthesis of 1,2-bis-(tert-butyldimethylsilanyloxy)benzene (11) 
A solution of catechol (0.1 g, 0.91 mmol) and imidazole (0.14 g, 1.99 mmol) 1 mL 
dichloromethane was stirred at 00C under nitrogen atmosphere.  tert-Butyldimethylsilyl chloride 
(0.30 g, 1.99 mmol), dissolved in 1 mL of dichloromethane, was added dropwise. The reaction 
mixture was allowed to warm up to room temperature, then stirred for four hours. The reaction 
was quenched with 2 mL water and extracted with dichloromethane three times (9 mL). The 
organic layer was washed twice with water and once with brine and dried over anhydrous 
sodium sulfate. The organic layer was concentrated and the residue was purified using flash 
column chromatography (silica gel, Hexane) to yield a colorless oil (0.239g, 77 %).  1H-NMR 
(CDCl3):  δ 6.82 (dt, J = 9.9, 2.7 Hz, 4H), 0.99 (s, 18H), 0.25-0.13 (12H).13C-NMR: δ 147.01 
(ArC), 121.50 (ArC), 121.28 (ArC), 25.93 (CH3), 18.55 (C). 
 
Synthesis of 2-bromo-1-(tert-butyldimethylsilanyloxy)ethane (12) 
To a round bottom flask containing 2.00 g (16 mmol) of bromoethanol and 1.20 g 
imidazole (18 mmol), dissolved in 10 mL dichloromethane and stirred at 00C under nitrogen 
atmosphere, was added dropwise a solution of 2.65 g (18 mmol) tert-butyldimethylsilyl chloride 
in 10 mL of dichloromethane. The mixture was allowed to warm up to room temperature and 
stirred for four more hours. The reaction was quenched with 20 mL water and then extracted 
with dichloromethane (40 mL). The organic layer was washed twice with water (10 mL) and 
once with brine (10 mL) and dried over anhydrous sodium sulfate then concentrated. The residue 
was purified using flash column chromatography (silica gel, Hexane/dichloromethane/ 2: 1, v/v) 
to yield a colorless oil (3.29g, 81%).  1H-NMR (CDCl3):  δ 3.87 (t, J = 6.6 Hz, 2H), 3.38 (t, J = 
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6.6 Hz, 2H), 0.92-0.86 (9H), 0.08 (d, J = 3.3 Hz, 6H).  13C-NMR: δ 63.59 (CH2), 33.32 (CH2), 
25.90 (CH3), 18.40 (C). 
 
Synthesis of 1,2-methylenedioxybenzene (15) 
To a refluxing mixture of DMSO (1 ml), dichloromethane (0.2 mL), and 
tetrabutylammonium bromide (0.016 g, 0.05 mmol) was added simultaneously a solution of 
catechol (0.1 g, 0.91 mmol) in DMSO (0.6 mL) and 50 % sodium hydroxide (0.07 g, 1.82 mmol) 
over a period of two hours. Afterward, the reaction mixture was further refluxed for an additional 
hour.119 The reaction was quenched slowly with 100 ml water and the product was separated 
from the crude by distillation under reduced pressure.119 The distillates containing 15 and water 
was separated by a separating funnel and dried over anhydrous sodium sulfate obtained a 61.4 % 
yield of the colorless liquid.  
 
Synthesis of 4-bromocatechol (18) 
To a solution of 0.10 g catechol in 1 mL dichloromethane stirring under nitrogen 
atmosphere at 0 0C was added dropwise (10 drops per minute) a solution of 0.145 g bromine in 1 
mL dichloromethane. The reaction mixture was allowed to warm up to room temperature, then 
stirred for four more hours. The reaction was quenched with 0.5 mL of distilled water and then 
extracted three times with 2 mL dichloromethane; the combined organic layer was washed with 
saturated sodium chloride. The solvent was evaporated in vacuo to give a dark brown crude 
product (1.92 g). Recrystallization of the product from dichloromethane/petroleum ether (3:2, 
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v/v) yielded a light gray solid (1.4 g, 82 %). 1H-NMR (CDCl3):  δ 7.02 (d, J = 2.2 Hz, 1H), 6.92 
(dd, J = 8.4, 2.2 Hz, 1H), 6.74 (d, J = 8.4 Hz, 1H). 13C-NMR: δ 142.79 (ArC), 124.05 (ArC), 
118.73 (ArC), 116.74 (ArC). 
 
Synthesis of 4-bromo-1,2-bis-(tert-butyldimethylsilanyloxy)benzene (19) 
To a solution of 0.10 g (0.5 mmol) of 4-bromocatechol and 0.079 g (1.16 mmol) of 
imidazole in 1 mL dichloromethane in a round bottom flask, with stirring at 00C under nitrogen 
atmosphere, was added dropwise a solution of 0.173 g (1.16 mmol) of tert-butyldimethylsilyl 
chloride in 1 mL dichloromethane. The mixture was allowed to warm up to room temperature 
and stirred for four more hours. The reaction was quenched with 2 mL water and then extracted 
with dichloromethane (8 mL). The organic layer was washed twice with water and once with 
brine and dried over anhydrous sodium sulfate. Evaporation of the solvent and purification by 
flash column chromatography yielded a colorless oil (0.173 g, 78 %). 1H-NMR (CDCl3): δ 6.93 
(td, J = 8.5, 2.4 Hz, 2H), 6.69 (d, J = 8.4 Hz, 1H), 1.06-0.92 (m, 18H), 0.29-0.11 (12H). 13C-
NMR: δ 147.95 (ArC), 146.47 (ArC), 125.39 (ArC), 124.33 (ArC), 122.27 (ArC), 112.81 (ArC), 
25.97 (CH3), 18.54 (C). 
 
General Procedure for the Esterification of Alcohols Using acetyl chloride 
To a flask containing a solution of the corresponding alcohol and triethylamine (1.5 eq. 
per OH group) in THF, stirred at 0 0C under a nitrogen atmosphere, was added dropwise acetyl 
chloride (1.5 eq. per OH). After addition was complete, the mixture was allowed to warm up to 
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room temperature and stirred for 5 hours. Saturated ammonium chloride was then added and the 
resulting precipitate was filtered. The filtrate was then extracted three times with 
dichloromethane. Evaporation of the solvent yielded the corresponding ester. 
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CHAPTER 3 
RESULTS AND DISCUSSIONS 
 
Several methods for the synthesis of hydroxytyrosol (1) have been reported in literature. 
However, only a few of these methods are industrially applicable. To begin, several synthetic 
methods were proposed for the synthesis of hydroxytyrosol. The architecture of the various 
methods was based on some factors such as the cost and availability of the starting materials, 
number of reaction steps in the method as well as the overall cost of the entire process.  
 
Friedel-Crafts Acylation Approach 
The Friedel-Crafts acylation provides a means by which acyl substituents can be added to 
a benzene ring via an electrophilic aromatic substitution. These substituents can then be further 
reacted to give desired products. Using this approach, hydroxytyrosol was successfully 
synthesized from commercially available catechol (2) through a four-step process depicted in 
scheme 6.  
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Scheme 6: Synthesis of hydroxytyrosol  
 
The first step involves acylation of 2 using acetyl chloride as the acylating agent in the 
presence of a Lewis acid catalyst (aluminum chloride). Initial attempt to synthesize 3,4-
Diacetoxyacetophenone (4) involved using 1:1 molar ratio (catechol: acetyl chloride) gave only 
low yield of 4 (Rf = 0.79, CH2Cl2/EtOAc, 3:1 v/v) in addition to 6 (Rf = 0.85), 7 (Rf = 0.47), and 
3 (Rf = 0.39). The low yield may be due to insufficient the acylating agent. Using excess amount 
of the acylating agent improved the percent yield of the reaction. The crude brown product was 
purified by recrystallization using CH2Cl2/hexane (1:4, v/v) to give 4 as brownish white crystals 
(79% yield). The presence of 6 among the products formed may be an indication that the rate of 
addition of the catechol during the reaction may have been high causing an excess of the catechol 
in the reaction mixture which got esterified before a change of acylation. 
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Scheme 7: Acylation of catechol.  
 
To improve the yield of 4 and reduce the diversity of products formed, a different 
approach based on a procedure described by Payne et al.120 was used in the synthesis of 7. In this 
procedure, a mixture of aluminum chloride and 1,2-dibromoethane was stirred for 30 minutes 
after which catechol was added and further stirred for 30 minutes before the introduction of the 
acylating agent (acetyl chloride).  
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Scheme 8: Synthesis of 3,4-diacetoxyacetophenone. 
 
This initial reaction may have offered partial protection from the 1,2-dibromoethane, to 
the hydroxy groups on the catechol, thereby reducing the chances of esterification of the groups 
which may lower the nucleophilicity of the ring towards the acylium ion. Using this procedure 3 
was synthesized in high yield (97 %) which was further esterified to give 4 with a yield of 94%.   
The second step involves converting 4 into 5 (Scheme 9), using a procedure reported in 
literature by Myrboh et al.118 The proposed reaction mechanism involves enolization of the 
ketone, assisted by the boron trifluoride etherate, accompanied by oxyplumbation leading to the 
formation of intermediate 8, which rearranges to 5.118 The dark brown oily crude product was 
used for the next step without further purification. 
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Scheme 9: Mechanism for synthesis of methyl (3,4-diacetoxyphenyl)acetate 
 
   In the final step, crude 5 was reduced by lithium aluminum hydride to afford 0.049 g (87 
%) of 1 after purification by column chromatography as light yellow oil. The physical properties 
and NMR analysis of 1 were consistent with those reported in literature. 
 A different synthetic path earlier proposed, in this research for the synthesis of 1, uses 
chloroacetyl chloride as the acylating agent.  
Scheme 10: Proposed route for synthesis of hydroxytyrosol using chloroacetyl chloride as 
         acylating agent. 
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The first step of this method involves the acylation of 2 using chloroacetyl chloride, this 
is then followed by reduction of the ketone and subsequent substitution reaction of the halide to 
give 1. This method was challenged by a low yield of the desired acylated product in the first 
step. A reason for the low yield may be due to the formation of a complex during the reaction 
and as such this method is still under investigation. 
 
Direct Friedel-Crafts Alkylation Approach 
Several authors have successfully carried out alkylation on phenolic compounds. In this 
work, attempts were made to alkylate catechol directly with 2-bromoethanol. 
 
Scheme 11: Friedel-Crafts alkylation of catechol using bromoethanol 
 
  The process started by attempting to carry out a Friedel-Crafts alkylation reaction on 
catechol using bromoethanol as both the alkylating agent and as the solvent in the presence of a 
Lewis acid (aluminum chloride) catalyst. The presence of reactive hydroxyl groups on both the 
catechol and bromoethanol was anticipated to pose problems during the reaction, as this group 
may react with the aluminum chloride to form an aluminum alkoxide. On the other hand, this 
seemly disadvantageous condition may, in fact, help to mask the hydroxyl groups and allow the 
reaction proceed to completion upon using excess AlCl3. The reaction mixture almost 
immediately formed a dark brown precipitate with evolution of white fume (believed to be HCl), 
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the starting material was recovered after work up. At this point, it was unclear whether or not the 
reaction would have continued in the presence of a solvent that can dissolve the resulting 
precipitate. The reaction was repeated in various solvents, such as dichloromethane, 
tetrahydrofuran, acetonitrile, dioxane, petroleum ether and toluene, but did not yield any 
measurable amounts of the expected product.  
Owing to these unsuccessful attempts, the need to protect the hydroxyl groups seemed 
more apparent. Several authors have reported the use of different protection groups, such as 
ethers93, methylene acetal94, and esters95, in masking alcohol groups. 
 
Protection of OH Groups 
 Several groups for the protection of alcohol compounds are reported in literature.121 
However, there are certain factors that were considered during the selection of protecting groups 
used in this research. Among these factors, efficiency of protection and deprotection steps and 
the commercial availability of starting materials. In view of these factors, 9 – 14 were 
synthesized using various protecting groups. 
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Figure 1: Derivatives of catechol and bromoethanol with different protection groups. 
 
There is a broad range of ether protection documented in the literature for obtaining 
derivatives of alcohol compounds. However, one of the most common is the use of organosilicon 
compound. One of the main reasons for selecting this type of protection was because this group 
can be easily removed by tetrabutylammonium fluoride. 
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Synthesis of (2-bromoethoxy)trimethylsilane (9) 
The initial attempt to protect the alcohol group of the 2-bromoethanol involved a reaction 
containing a mixture of pyridine and trimethylsilyl chloride in dichloromethane. 93 The reaction 
yielded only 11 % of colorless oil, after18 hours.  
The silyl ether derivative of bromoethanol was synthesized in higher yield by using a 
modified version of a procedure reported by Corey and Snider during the total synthesis of (+-)-
fumagilli96 upon treatment of the alcohol with trimethylsilyl chloride/triethylamine in 
tetrahydrofuran. 9, a colorless oil was obtained in 84 % yield, after purification. 
 
Scheme 12: Synthesis of (2-bromoethoxy)trimethylsilane 
 
The initial TLC analysis of this crude product with dichloromethane showed two spots, 
none of them corresponded to bromoethanol starting material, which indicates that the reaction 
was complete. After washing of the reaction mixture with saturated ammonium chloride, the 
product was further purified by distillation to yield 1.97 g (84 %) of colorless oil. 1H NMR 
analysis of the product shows two triplets and a singlet with integration matching those predicted 
for the product. 
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Synthesis of 1,2-bis-(trimethylsilyloxy)benzene (10) 
The procedure for the synthesis of  3 was similar to the modified procedure used in the 
synthesis of (2-bromoethoxy) trimethylsilane. The reaction which was carried out under an inert 
atmosphere and afforded 79 % yield of colorless oil. The low yield may be due to incomplete 
reaction; TLC analysis showed some unreacted catechol starting material. After washing the 
crude product with saturated ammonium chloride, and purification by column chromatography, 
2.04 g (79 %) of colorless oil was obtained. Proton NMR analysis of the product showed two 
singlets, and the integration matched those predicted for 10. 
 
Scheme 13: Synthesis of 1,2-bis-(trimethylsilyloxy)benzene 
 
Friedel-Crafts Alkylation 
After protection of the alcohol groups of both bromoethanol and catechol, attempts were 
made to conduct the Friedel-Craft’s alkylation. The reactions showed no significant difference in 
the yield when the reaction was carried out in the presence or absence of the solvent 
(dichloromethane).  
The methylene acetal derivative 15 was alkylated with the ester derivative of 2-
bromoethanol (14) in the presence of aluminum chloride. TLC analysis of the crude product 
showed three spots, both of the starting materials as well as the expected product 16 (3,4-
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Methylendioxy-phenaethyl -acetate). Although TLC analysis after column chromatographic 
separation of product 16 showed one spot,  the 1H NMR spectrum (Appendix K) however, 
showed the presence of impurities. This may be an indication that the impurities are invisible 
under UV light. 
 
Scheme 14: Synthesis of 3,4-Methylendioxy-phenethyl acetate 
 
The unsuccessful attempt to carry out the Friedel-Craft’s alkylation of 13 with 2-
bromoethyl acetate 14 may be due to the presence of the two acetoxy groups on the aromatic 
compound. This may have caused the delocalization of the lone pair of electron on the oxygen 
connected to the aromatic ring which may in turn lower the nucleophilicity of the aromatic ring 
 
 
 Scheme 15: Synthesis of 3,4-diacetoxy-phenethyl acetate. 
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towards the carbocation formed from 14. This was evident as a similar alkylation reaction 
involving phenyl acetate and 14 yielded only about 9 % of the alkylated product (4-
acetoxyphenethyl acetate). 
 
 Scheme 16: Synthesis of 4-acetoxyphenethyl acetate. 
 
The reaction between 9 and  10 was performed under similar alkylation conditions. The 
reaction mixture, which turned orange after 3 hours, was allowed to stir at room temperature for 
8 hours. TLC showed four spots, the first two spots were comparable to those of the starting 
materials, an indication that the reaction was not complete. The slower spots were interestingly 
comparable to those of the unprotected starting materials which were further confirmed by NMR. 
The formation of unprotected starting materials suggests that deprotection may have occurred. 
The trimethylsilyl (TMS) protecting group is known to be somewhat unstable under acidic 
reaction conditions, this may have resulted in deprotection. 
 
Grignard’s Reaction  
Grignard reaction provides a good way to alkylate aromatic compounds. Aryl magnesium 
halides react with alkyl halides to give alkyl aromatic products. In a similar fashion, a Grignard 
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reagent of the protected bromocatechol can react with protected 2-bromoethanol to give a 
derivative of hydroxytyrosol which can be converted into hydroxytyrosol by deprotection. 
  
Scheme 17: Proposed Grignard’s reaction route for synthesis of hydroxytyrosol. 
 
In an earlier approach, attempts were made to first protect catechol with TMS before 
bromination. These attempts were unsuccessful and resulted in deprotection.  Alternatively, 
bromination of unprotected catechol, followed by protection with tert-butyldimethylsilyl chloride 
(TBDMSCl) proved to be more successful. 
 
Synthesis of 4-bromo-1,2-bis-(tertbutyldimethyl silanyloxy)benzene (19)  
  Monobrominated catechol upon reaction with bromine in dichloromethane gave 82 % 
yield of light gray solid after recrystallization from dichloromethane/petroleum ether (3:2, v/v). 
TLC analysis of the product showed one spot with a Rf value of 0.52 
(dichloromethane/petroleum ether 3:1, v/v). 1H NMR showed peaks at δ 7.02 (d, J = 2.2 Hz, 1H),  
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δ  6.92 (dd, J = 8.4, 2.2 Hz, 1H),  and δ  6.74 (d, J = 8.4 Hz, 1H). Integration of the individual 
peaks gave an approximate ratio of 1: 1: 1 suggesting that the compound had only three aromatic 
protons as predicted. 
Treatment of the bromocatechol (18) with TBDMSCl in dichloromethane in the presence 
of triethylamine afforded 19 as a colorless oil with 78 % yield. TLC analysis of the product 
showed two  spots, none of which correspond to 4-bromocatechol suggesting the reaction was 
complete; 
 
Scheme 18: Synthesis of 4-Bromo-1,2-bis-(tert-butyldimethylsilanyloxy)benzene. 
 
 the spots were separated by column chromatography. Proton NMR analysis of the slower spot 
showed that the reaction resulted in product 19, accompanied with about 5 % of the 
monoprotected bromocatechol (20). Formation of monoprotected bromocatechol may be due to 
inadequate amounts of TBDMSCl or due to insufficient reaction time. 
1H NMR analysis of the product (4-bromo-1,2-bis-(tertbutyldimethyl silanyloxy)benzene 
showed two singlets at δ 0.97  and δ0.19, two doublets one at δ 6.94 – 6.93 and another at δ 6.70 
– 6.67, and doublet of doublets in the range of δ 6.93 - 6.90.  
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Several attempts to synthesize the hydroxytyrosol derivative from the Grignard reaction 
of 19 and the protected 2-bromethanol 12 were not successful. It is still unclear why the starting 
material 19 failed to form the Grignard reagent; this reaction is still under investigation. 
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CHAPTER 4 
CONCLUSION 
 
In this research work, various synthetic routes were explored for the synthesis of 
hydroxytyrosol (1) using commercially available catechol (2) precursor. These routes include: 
Friedel-Craft’s acylation, direct Friedel-Craft’s alkylation, and Grignard’s Reaction.  Friedel-
Craft’s acylation route produced the best result with high overall yield. The method involves four 
steps wherein the intermediates can be isolated in good yields.  On the other hand, Friedel-
Craft’s alkylation method gave a low yield of 1.  Other attempts were made to synthesize 1 using 
methods such as Grignard’s reaction; however, the synthesis of Grignard reagent 19 was not 
successful. 
Future work will focus on optimization of reaction conditions for synthesis of 1, as well 
as an assessment of its ability to inhibit DNA oxidative damage. 
 
 
 
 
 
 
55 
 
REFERENCES 
1. Malik, P.; Mukherjee, T.K. Structure-function elucidation of antioxidative and prooxidative 
activities of the polyphenolic compound curcumin. Chin. J. Bio. 2014, 2014 
https://www.hindawi.com/archive/2014/396708/cta/ (accessed Oct, 2016) 
2. Bouallagui, Z.; Han, J.; Isoda, H.; Sayadi, S. Hydroxytyrosol rich extract from olive leaves 
modulates cell cycle progression in MCF-7 human breast cancer cells. Food Chem. Toxicol. 
2011, 49(1), 179-84. 
3. Csiszar, A.; Smith, K.; Labinskyy, N.; Orosz, Z.; Rivera, A.; Ungvari, Z. Resveratrol 
attenuates TNF-α-induced activation of coronary arterial endothelial cells; role of NF-κB 
inhibition. Am J Physiol Heart Circ Physiol. 2006, 291(4), 1694-1699. 
4. Benavente-Garcıa, O.; Castillo, J.; Lorente, J.; Ortuno, A.; Del Rio, J.A. Antioxidant activity 
of phenolics extracted from Olea europaea L. leaves. Food Chem. 2000, 68(4), 457-462. 
5. Bravo L. Polyphenols: Chemistry, Dietary Sources, Metabolism, and Nutritional 
Significance. Nutr. Rev. 1998, 56, 317–333. 
6. Cheynier V. Polyphenols in foods are more complex than often thought. Am. J. Clin. 
Nutr. 2005, 81, 223S–229S. 
7. Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jiménez, L. Polyphenols: food sources and 
bioavailability. Am J Clin Nut. 2004, 79(5), 727-747. 
8. Milner J.A. Reducing the risk of cancer. In; Goldberg I., editor. Functional Foods; Designer 
Foods, Pharmafoods, Nutraceuticals. Chapman & Hall; New York, NY, USA, 1994; pp. 39–
70. 
56 
 
9. Duthie G.G. Brown K.M. Reducing the risk of cardiovascular disease. In Goldberg I.; 
editor. Functional Foods; Designer Foods, Pharmafoods, Nutraceuticals. Chapman & Hall; 
New York, NY, USA, 1994; pp. 19–38. 
10. Tsao, R. Chemistry and biochemistry of dietary polyphenols. Nutrients. 2010, 2(12), 1231-
1246. 
11. ChemGuide, The Acidity of Phenol. 
http://www.chemguide.co.uk/organicprops/phenol/acidity.html (accessed May 3, 2017). 
12. Scalbert A, Manach C, Morand C, Rémésy C, Jiménez L. Dietary polyphenols and the 
prevention of diseases. Crit Rev Food Sci Nutr. 2005, 45, 287–306. 
13. Romero, C.; Medina, E.; Vargas, J.; Brenes, M.; De Castro, A. In Vitro Activity of Olive Oil 
Polyphenols against Helicobacter pylori. J. Agric. Food Chem. 2007, 55, 680-686. 
14. Song, J.-M.; Lee, K.-H.; Seong, B.-L. Antiviral effect of catechins in green tea on influenza 
virus. Antiviral Res. 2005, 68, 66-74. 
15. Nitta, Y.; Kikuzaki, H.; Ueno, H. Food components inhibiting recombinant human histidine 
decarboxylase activity. J. Agric. Food Chem. 2007, 55, 299-304. 
16. Macheix, J.-J.; Fleuriet, A.; Billot, J. Fruit Phenolics; CRC Press, Inc.; Boca Raton, 1990; 
pp. 272-273. 
17. Bertelli, A.A.; Das, D.K. Grapes, wines, resveratrol, and heart health. J Cardiovasc 
Pharmacol. 2009, 54(6), 468-76. 
18. Dohadwala, M.M.; Vita, J.A. Grapes and cardiovascular disease. J. Nutr. 2009, 139(9), 
1788S-93S. 
19. Visioli, F.; Bellomo, G.; Galli, C. Free radical-scavenging properties of olive oil 
polyphenols. Biochem. Biophys. Res. Commun. 1998, 247(1), 60-64. 
57 
 
20. Scalbert, A.; Morand, C.; Manach, C.; Rémésy, C. Absorption and metabolism of 
polyphenols in the gut and impact on health. Biomed Pharmacother. 2002, 56(6), 276-82. 
21. Jovanovic, S.V; Steenken, S.; Simic, M.G.; Hara, Y. Antioxidant properties of flavonoids 
reduction potentials and electron transfer reactions of flavonoid radicals. In: C Rice Evans, L 
Packer, editor. Flavonoids in Health and Disease; Marcel Dekker, NY, USA, 1998; pp.137–
161. 
22. Rice-Evans, C.A.; Miller, N.J.; Paganga, G. Structure-antioxidant activity relationships of 
flavonoids and phenolic acids. Free Radic Biol Med. 1996, 20(7), 933-56. 
23. Ragazzi, E.; Veronese, G. Indagini sui componenti fenolici degi oli di oliva. Riv. Ital. 
Sostanze Grasse. 1973, 50, 443-452. 
24. Ragazzi, E.; Veronesi, G. Ricerche sui costituenti idrosolubili delle olive. I. Zuccheri e 
fenoli. Ann. Chim. 1967, 57, 1476-1486. 
25. Amiot, M. J.; Fleuriet, A.; Macheix, J. J. Accumulation of oleuropein derivatives during 
olivematuration. Phytochemistry. 1989, 28, 67-69. 
26. Bernini, R.; Merendino, N.; Romani, A.; Velotti, F. Naturally occurring hydroxytyrosol; 
synthesis and anticancer potential. Curr. Med. Chem. 2013, 20(5), 655-670 
27. Stoll, A. Renz, J.and Brack, A. Antibacterial materials. VI. Isolation and constitution of 
echinacoside, a glycoside from the roots of Echinacea angustifolia D.C. Helv. Chim. Acta, 
1950, 33, 1877-1893. 
28. Romero, C.; Brenes, M.; Yousfi, K.; Garcia, P.; Garcia, A.; Garrido, A. Effect of cultivar and 
processing method on the contents of polyphenols in table olives. J. Agric. Food Chem. 
2004, 52, 479-484. 
58 
 
29. Gambacorta, A.; Tofani, D.; Bernini, R.; Migliorini, A. High-yielding preparation of a stable 
precursor of hydroxytyrosol by total synthesis and from the natural glycoside oleuropein. J. 
Agric. Food Chem. 2007, 55(9), 3386-3391. 
30. Montedoro, G.; Servili, N.; Baldioli, M.; Miniati, E. Simple and hydrolyzable phenolic 
compounds in virgin olive oil. 1. Their extraction, separation, and quantitative and 
semiquantitative evaluation by HPLC. J. Agric. Food. Chem. 1992, 40, 1571- 1576. 
31. Lucarini, M.; Pedulli, G.F.; Cipollone, M. Bond dissociation enthalpy of. alpha.-tocopherol 
and other phenolic antioxidants. J. Org. Chem. 1994, 59(17), 5063-70. 
32. Rogaie, R.S.; Nosratollah, Z.; Abolfazl, B.; Akram, E.; Abolfazl, A.; Mustafa, R.T. Studies 
of the relationship between structure and antioxidant activity in interesting systems, 
including tyrosol, hydroxytyrosol derivatives indicated by quantum chemical calculations. 
Scientific Research Publishing. Soft. [Online] 2013, 2, 13-18. 
https://www.scirp.org/journal/PaperInformation.aspx?PaperID=36611 (accessed May 1, 
2017) 
33. Lobo, V.; Patil, A.; Phatak, A.; Chandra, N. Free radicals, antioxidants and functional foods; 
Impact on human health. Pharmacogn Rev. 2010, 4(8), 118. 
34. Cheeseman, K.H.; Slater, T.F. An introduction to free radical biochemistry. Br. Med. Bull. 
1993, 49(3), 481-93. 
35. Bagchi, K.; Puri, S. Free radicals and antioxidants in health and disease. East. Mediterr. 
Health J. 1998, 4(2), 350-60. 
36. Diplock, A.T.; Charuleux, J.L.; Crozier-Willi, G.; Kok, F.J.; Rice-Evans, C.; Roberfroid, 
M.; Stahl, W.; Vina-Ribes, J. Functional food science and defence against reactive oxidative 
species. Br. J. Nutr. 1998, 80(S1), S77-112. 
59 
 
37. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M.T.; Mazur, M.; Telser, J. Free radicals and 
antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell 
Biol. 2007, 39(1), 44-84. 
38. Miller, D.M.; Buettner, G.R.; Aust, S.D. Transition metals as catalysts of “autoxidation” 
reactions. Free Radic Biol Med. 1990, 8(1), 95-108. 
39. Valko, M.M.H.C.M.; Morris, H.; Cronin, M.T.D. Metals, toxicity and oxidative stress. Curr. 
Med. Chem. 2005, 12(10), 1161-208. 
40. Cadenas, E.; Sies, H. The lag phase. Free radical research. 1998, 28(6), 601-609. 
41. Kovacic, P.; Pozos, R.S.; Somanathan, R.; Shangari, N.; O'Brien, P.J. Mechanism of 
mitochondrial uncouplers, inhibitors, and toxins; focus on electron transfer, free radicals, 
and structure-activity relationships. Curr. Med. Chem. 2005, 12(22), 2601-2623. 
42. Valko, M.; Izakovic, M.; Mazur, M.; Rhodes, C.J.; Telser, J. Role of oxygen radicals in 
DNA damage and cancer incidence. Mol Cell Biochem. 2004, 266(1-2), 37-56. 
43. Stefanis, L.; Burke, R.E.; Greene, L.A. Apoptosis in neurodegenerative disorders. Curr 
Opin Neurol. 1997, 10(4), 299-305. 
44. Pastor, N.; Weinstein, H.; Jamison, E.; Brenowitz, M. A detailed interpretation of OH 
radical footprints in a TBP-DNA complex reveals the role of dynamics in the mechanism of 
sequence-specific binding. J. Mol. Biol. 2000, 304(1), 55-68. 
45. Gerschman, R.; Gilbert, D.L.; Nye, S.W.; Dwyer, P.; Fenn, W.O. Oxygen poisoning and x-
irradiation; a mechanism in common. Science. 1954, 119(3097), 623-626. 
46. Harman, D. Aging; a theory based on free radical and radiation chemistry. J. Gerontol. 
1955, 11, 298-300. 
60 
 
47. Hybertson, B.M.; Gao, B.; Bose, S.K.; McCord, J.M. Oxidative stress in health and disease; 
the therapeutic potential of Nrf2 activation. Mol Aspects Med. 2011, 32(4), 234-46. 
48. Wong, M. H. Environmental contamination; Health risks and ecological restoration; CRC 
press: New York; 2012 pp 37-38. 
49. McCord, J.M. The evolution of free radicals and oxidative stress.  Am. J. med. 2000, 108(8), 
652-9. 
50. Hwang, E.S.; Bowen, P.E. DNA damage, a biomarker of carcinogenesis; its measurement 
and modulation by diet and environment. Crit Rev Food Sci Nutr. 2007, 47(1), 27-50. 
51. Seril, D.N.; Liao, J.; Yang, G.Y.; Yang, C.S. Oxidative stress and ulcerative colitis-
associated carcinogenesis; studies in humans and animal models. Carcinogenesis. 2003, 
24(3), 353-362. 
52. Konturek, P.C.; Konturek, S.J.; Brzozowki, T. Gastric cancer and Helicobacter pylori 
infection. J Physiol Pharmacol. 2006, 57(Suppl 3), 51-65. 
53. Klaunig, J.E.; Xu, Y.; Isenberg, J.S.; Bachowski, S.; Kolaja, K.L.; Jiang, J.; Stevenson, 
D.E.; Walborg Jr, E.F. The role of oxidative stress in chemical carcinogenesis. Environ 
Health Perspect. 1998, 106(Suppl 1), 289–295. 
54. Trush, M.A.; Kensler, T.W. An overview of the relationship between oxidative stress and 
chemical carcinogenesis. Free Radic Biol Med. 1991, 10(3-4), 201-209. 
55. Wickens, A.P. Ageing and the free radical theory. Respir Physiol. 2001, 128(3), 379-91. 
56. Ashok, B.T.; Ali, R. The aging paradox; free radical theory of aging. Exp Gerontol. 1999, 
34(3), 293-303. 
57. Cantuti-Castelvetri, I.; Shukitt-Hale, B.; Joseph, J.A. Neurobehavioral aspects of 
antioxidants in aging. Int. J. Dev. Neurosci. 2000, 18(4), 367-81. 
61 
 
58. Fernandez-Bolanos, J.G.; Lopez, O.; Fernandez-Bolanos, J.; Rodriguez-Gutierrez, G. 
Hydroxytyrosol and derivatives; isolation, synthesis, and biological properties. Curr. Org. 
Chem. 2008, 12(6), 442-63. 
59. Morales, M.T.; Przybylski, R. Olive oil oxidation. In Handbook of olive oil; Harwood, J., 
Aparicio, R., Eds.; Springer Science+Business Media: New York, 2000; pp. 459-490. 
60. de Pinedo, A.T.; Peñalver, P.; Morales, J.C. Synthesis and evaluation of new phenolic-based 
antioxidants; Structure–activity relationship. Food Chem. 2007, 103(1), 55-61. 
61. Fernández-Bolaños, J.G.; Marset, A.; López-García, M.Á.; López, Ó. Biological properties 
of hydroxytyrosol and its derivatives. INTECH Open Access Publisher; 2012. 
62. Goya, L.; Mateos, R.; Bravo, L. Effect of the olive oil phenol hydroxytyrosol on human 
hepatoma HepG2 cells. Eur. J. Nutr. 2007, 46(2), 70-8. 
63. Geerlings, A.; López-Huertas, E.; Morales, J.C.; Boza, J.; Jiménez, J. Natural phenolic 
products and derivatives thereof for protection against neurodegenerative diseases. US. 
Patent US20030236202 Oct 9, 2003. 
64. Herrera-Gutierrez, M.E.; Seller-Pérez, G.; Lebrón-Gallardo, M.; de la Cruz-Cortés, J.P.; 
González-Correa, J.A. Uso de epoprostenol aislado o asociado a heparina para el 
mantenimiento de la permeabilidad de los circuitos de técnicas continuas de reemplazo 
renal. Med. Intensiva. 2006, 30(7), 314-21. 
65. Turner, R.; Etienne, N.; Garcia Alonso, M.; de Pascual-Teresa, S.; Minihane, A.M.; 
Weinberg, P.D.; Rimbach, G. Antioxidant and anti-atherogenic activities of olive oil 
phenolics. Int J Vitam Nutr Res. 2005, 75(1), 61-70. 
66. Aruoma, O.I.; Deiana, M.; Jenner, A.; Halliwell, B.; Kaur, H.; Banni, S.; Corongiu, F.P.; 
Dessí, M.A.; Aeschbach, R. Effect of hydroxytyrosol found in extra virgin olive oil on 
62 
 
oxidative DNA damage and on low-density lipoprotein oxidation. J. Agric. Food Chem. 
1998, 46(12), 5181-7. 
67. González-Santiago, M.; Fonollá, J.; Lopez-Huertas, E. Human absorption of a supplement 
containing purified hydroxytyrosol, a natural antioxidant from olive oil, and evidence for its 
transient association with low-density lipoproteins. Pharmacol Res. 2010, 61(4), 364-70. 
68. Petroni, A.; Blasevich, M.; Salami, M.; Papini, N.; Montedoro, G.F.; Galli, C. Inhibition of 
platelet aggregation and eicosanoid production by phenolic components of olive oil. Thromb 
Res. 1995, 78(2), 151-60. 
69. Visioli, F.; Galli, C. The effect of minor constituents of olive oil on cardiovascular disease; 
new findings. Nutr. Rev. 1998, 56(5), 142-7. 
70. Visioli, F.; Bellomo, G.; Montedoro, G.; Galli, C. Low density lipoprotein oxidation is 
inhibited in vitro by olive oil constituents. Atherosclerosis. 1995, 117(1), 25-32. 
71. Visioli, F.; Galli, C. Oleuropein protects low density lipoprotein from oxidation. Life Sci. 
1994, 55(24), 1965-71. 
72. Manna, C.; Galletti, P.; Cucciolla, V.; Moltedo, O.; Leone, A.; Zappia, V. The protective 
effect of the olive oil polyphenol (3, 4-dihydroxyphenyl)-ethanol counteracts reactive 
oxygen metabolite–induced cytotoxicity in Caco-2 cells. J. Nutr. 1997, 127(2), 286-92. 
73. Manna, C.; Galletti, P.; Cucciolla, V.; Montedoro, G.; Zappia, V. Olive oil hydroxytyrosol 
protects human erythrocytes against oxidative damages. J. Nutr. Biochem. 1999, 10(3), 159-
65. 
74. Deiana, M.; Aruoma, O.I.; Maria de Lourdes, P.B.; Spencer, J.P.; Kaur, H.; Halliwell, B.; 
Aeschbach, R.; Banni, S.; Dessi, M.A.; Corongiu, F.P. Inhibition of peroxynitrite dependent 
63 
 
DNA base modification and tyrosine nitration by the extra virgin olive oil-derived 
antioxidant hydroxytyrosol. Free Radic Biol Med. 1999, 26(5), 762-9. 
75. Vauzour, D.; Rodriguez-Mateos, A.; Corona, G.; Oruna-Concha, M.J.; Spencer, J.P. 
Polyphenols and human health; prevention of disease and mechanisms of action. Nutrients. 
2010, 2(11), 1106-31. 
76. Psaltopoulou, T.; Kosti, R.I.; Haidopoulos, D.; Dimopoulos, M.; Panagiotakos, D.B. Olive 
oil intake is inversely related to cancer prevalence; a systematic review and a meta-analysis 
of 13800 patients and 23340 controls in 19 observational studies. Lipids Health Dis. 2011, 
10(1), 127. 
77. Umar, A. Dunn, B.K.; Greenwald, P. Future directions in cancer prevention. Nat. Rev. 
Cancer. 2012, 12(12), 835-48. 
78. Theisen, C. Chemoprevention, What’s in a Name?. J Natl Cancer Inst. 2001, 93(10), 743-
743. 
79. Sporn, M.B. Approaches to prevention of epithelial cancer during the preneoplastic 
period. Cancer res. 1976, 36(7 Part 2), 2699-2702. 
80. Steward, W.P.; Brown, K. Cancer chemoprevention; a rapidly evolving field. Br J Cancer. 
2013, 109(1), 1-7. 
81. Vidya Priyadarsini, R.; Nagini, S. Cancer chemoprevention by dietary phytochemicals; 
promises and pitfalls. Curr Pharm Biotechnol. 2012, 13(1), 125-36. 
82. Fabiani, R.; Rosignoli, P.; De Bartolomeo, A.; Fuccelli, R.; Servili, M.; Montedoro, G.F.; 
Morozzi, G. Oxidative DNA damage is prevented by extracts of olive oil, hydroxytyrosol, 
and other olive phenolic compounds in human blood mononuclear cells and HL60 cells. J. 
Nutr. 2008, 138(8), 1411-6. 
64 
 
83. Fabiani, R.D.B.A.; De Bartolomeo, A.; Rosignoli, P.; Servili, M.; Montedoro, G.F.; 
Morozzi, G. Cancer chemoprevention by hydroxytyrosol isolated from virgin olive oil 
through G1 cell cycle arrest and apoptosis. Eur. J. Cancer Prev. 2002, 11(4), 351-8. 
84. Fabiani, R.; Sepporta, M.V.; Mazza, T.; Rosignoli, P.; Fuccelli, R.; De Bartolomeo, A.; 
Crescimanno, M.; Taticchi, A.; Esposto, S.; Servili, M.; Morozzi, G. Influence of cultivar 
and concentration of selected phenolic constituents on the in vitro chemiopreventive 
potential of olive oil extracts. J. Agric. Food Chem. 2011, 59(15), 8167-74. 
85. Capasso, R.; Evidente, A.; Avolio, S.; Solla, F. A highly convenient synthesis of 
hydroxytyrosol and its recovery from agricultural waste waters. J. Agric. Food Chem. 1999, 
47, 1745-1748. 
86. Juan, C. E.; Cristina, S. R.; Emma, C.; Francisco, A.; Toma´s-Barbera´n.; Harry, J. W. 
Synthesis of the Antioxidant Hydroxytyrosol Using Tyrosinase as Biocatalyst. J. Agric. 
Food Chem. 2001, 49, 1187-1193. 
87. Capasso, R.; Cristinzio, G.; Evidente, A.; Scognamiglio, F. Isolation, spectroscopy and 
selective phytotoxic effects of polyphenols from vegetable waste waters. Phytochemistry, 
1992, 12, 4125-4128. 
88. Denis, D.; Philippe, G.; Stéphane, Q. Facile and sustainable synthesis of the natural 
antioxidant hydroxytyrosol. Tetrahedron Lett. 2014, 55, 2455–2458 
89. Bhatt, M. V.; Babu, J. R. Aluminium iodide in ether cleavage. Tetrahedron Lett. 1984, 
25(32), 3497-3500. 
90. Roberta, B.; Enrico, M.; Maurizio, B.; Fernanda, C.  Convenient Synthesis of 
Hydroxytyrosol and Its Lipophilic Derivatives from Tyrosol or Homovanillyl Alcohol. J. 
Agric. Food Chem, 2008, 58, 7408–7416. 
65 
 
91. Bovicelli, P.; Antonioletti, R.; Mancini, S.; Causio, S.; Borioni, G.; Ammendola, S.; 
Barontini, M. Expedient synthesis of hydroxytyrosol and its esters. Synth. Commun. 2007, 
37(23), 4245-52. 
92. Boskou, D. Preparation of hydroxytyrosol. Bull. Liaison-Groupe Polyphenols. 1992, 16, 
237–244. 
93. Moreau, C.l.; Roessac, F.; Conia, J. M. La thermocyclisation des alcenylphenols. 
Tetrahedron Lett. 1970, 11(40), 3527-3528. 
94. Geller, T.; Jakupovic, J.; Schmalz, H.G. Synthesis and structure of a novel twofold lactone-
bridged ternaphthyl. Tetrahedron Lett. 1998, 39(12), 1541-1544. 
95. Scheline, R. R. A Rapid Synthesis of 3-O-Methylgallic Acid. Acta Chem. Scand. 1966, 20, 
1182. 
96. Corey, E.J.; Snider, B.B. Total synthesis of (+-)-fumagillin. J Am Chem Soc. 1972, 94(7), 
2549-2550. 
97. Sofi, F.; Macchi, C.; Abbate R.; Gensini, G.F.; Casini, A. Mediterranean diet and health. 
Biofactors 2013, 39(4), 335–342. 
98. Keys, A.; Menotti, A.; Karvonen M.J.; Aravanis, C.; Blackburn, H.; Buzina, R.; Djordjevic, 
B.S.; Dontas, A.S.; Fidanza, F.; Keys M.H.; Kromhout, D.; Nedeljkovic, S.; Punsar, S.; 
Seccareccia, F.; Toshima H. The diet and 15-year death rate in the seven countries study. 
Am J Epidemiol 1986, 124, 903–915. 
99. Martín-Peláez, S.; Covas, M.I.; Fitó, M.; Kušar, A. Pravst I. Health effects of olive oil 
polyphenols,  recent advances and possibilities for the use of health claims. Mol Nutr Food 
Res 2013, 57(5), 760–771. 
66 
 
100. Visioli, F.; Bernardini, E.  Extra virgin olive oil’s polyphenols,  biological activities. Curr 
Pharm Des. 2011, 17, 786–804. 
101. Omar, S.H. Oleuropein in olive and its pharmacological effects. Sci Pharm. 2010, 78, 133–
154. 
102. Cicerale, S.; Lucas, L.J.; Keast, R.S. Antimicrobial, antioxidant and anti-inflammatory 
phenolic activities in extra virgin olive oil. Curr Opin Biotechnol. 2012, 23, 129–135. 
103. El, S.N; Karakaya, S. Olive tree (Olea europaea) leaves, potential beneficial effects on 
human health. Nutr Rev. 2009, 67, 632–638. 
104. Visioli, F.; Poli, A. Gall C. Antioxidant and other biological activities of phenols from 
olives and olive oil. Med Res Rev. 2002, 22, 65–75. 
105. Omar, S.H. Cardioprotective and neuroprotective roles of oleuropein in olive. Saudi Pharm 
J. 2010, 18(3), 111–121. 
106. Mukherjee, S.; Lekli I.; Gurusamy, N.; Bertelli A.A.; Das D.K. Expression of the longevity 
proteins by both red and white wines and their cardioprotective components, resveratrol, 
tyrosol, and hydroxytyrosol. Free Radic Biol Med. 2009, 46, 573–578. 
107. Kamtchouing, P.; Kahpui, S. M.; Djomeni Dzeufiet, P. D.; T’edong,  L.; Asongalem, E. A.; 
Dimoa, T. Anti-diabetic activity of methanol/methylene chloride stem bark extracts of 
Terminalia superba and Canarium schweinfurthii on streptozotocin-induced diabetic rats. J. 
Ethnopharmacol. 2006, 104, 306–309. 
108. Ceriello, A. Oxidative stress and glycemic regulation. Metabolism. 2000, 49, 27–29. 
109. Gumieniczek, A. Effects of pioglitazone on hyperglycemia-induced alterations in 
antioxidative system in tissues of alloxan-treated diabetic animals. Exp. Toxicol. Pathol. 
2005, 56, 321–326. 
67 
 
110. Chaudhry, J.; Ghosh, N. N.; Roy, K.; Chandra, R. Antihyperglycemic effect of a 
thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced 
diabetic rats. Life Sci. 2007, 80, 1135–1142. 
111. Karaoz, E.; Gultekin, F.; Akdogan, M.; Oncu, M.; Gokcimen, A. Protective role of 
melatonin and a combination of vitamin C and  vitamin E on lung toxicity induced by 
chlorpyrifos-ethyl in rats. Exp. Toxicol. Pathol. 2002, 54, 97–108. 
112. Al-Azzawie, H.; Alhamdani, M. S. S. Hypoglycemic and antioxidant effect of oleuropein in 
alloxan-diabetic rabbits. Life Sci. 2006, 78, 1371–1377. 
113. Jemai, H.; Bouaziz, M.; Fki, I.; El Feki, A.; Sayadi, S. Hypolipidimic and antioxidant 
activities of oleuropein and its hydrolysis derivative-rich extracts from Chemlali olive 
leaves. Chem.-Biol. Interact. 2008, 176, 88–98. 
114. Leonard, S.S.; Harris, G.K.; Shi, X. Metal-induced oxidative stress and signal 
transduction. Free Radic Biol Med. 2004, 37(12), 1921-1942. 
115. Health, United States, 2015; National Center for Health Statistics.: With Special Feature on 
Racial and Ethnic Health Disparities. Hyattsville, MD. 2016.  
116. Global report on diabetes 2016; World Health Organization, Geneva, 2016. 
117. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1, 
Diagnosis and classification of diabetes mellitus 1999. World Health Organization, Geneva, 
1999.  
118. Myrboh, B.; Ila, H.; Junjappa, H. One-Step Synthesis of Methyl Arylacetates from 
Acetophenones Using Lead (IV) Acetate. Synthesis. 1981, 2, 126-127. 
119. Gao, Y.; Liang, X.; Chen, Y.; Hu, F.; Liu, W.; Yu, P.; Hua, E., 2014. In A New Process for 
Preparation of Hydroxytyrosol, Proceedings of the 2012 International Conference on 
68 
 
Applied Biotechnology, Tianjin, China Oct 18-19, 2012; Zhang, T.C., Ouyang, P., Kaplan, 
S., Skarnes, B., Eds.; Springer:Verlag Berlin Heidelberg, 2014. 
120. Tran, A.T.; West, N.P.; Britton, W.J.; Payne, R.J. Elucidation of Mycobacterium 
tuberculosis type II dehydroquinase inhibitors using a fragment elaboration 
strategy. ChemMedChem. 2012, 7(6), 1031-1043. 
121. Wuts, P. G. M. Greene's Protective Groups in Organic Synthesis; Wiley-Interscience: New 
Jersey, 2006; pp 475-552. 
122. Lamprecht, M. Antioxidants in sport nutrition; CRC Press: New York, 2014; pp 28-29. 
123. Cooke, M. S.; Evans, M. D.; Dizdaroglu, M.; Lunec, J. Oxidative DNA damage: 
mechanisms, mutation, and disease. FASEB J, 2003. 17(10), 1195-1214. 
124. von Sonntag, C. The chemical basis of radiation biology; Taylor & Francis: London, 1987; 
pp. 221-294. 
125. Leopoldini, M.; Marino, T.; Russo, N.; Toscano, M. Antioxidant properties of phenolic 
compounds: H-atom versus electron transfer mechanism. J. Phys. Chem. A. 2004, 108(22), 
4916-4922. 
126. Jomova, K.; Vondrakova, D.; Lawson, M.; Valko, M. Metals, oxidative stress and 
neurodegenerative disorders. Mol. Cell. Biochem. 2010, 345(1-2), 91-104. 
127. Macomber, L.; Rensing, C.; Imlay, J. A. Intracellular copper does not catalyze the formation 
of oxidative DNA damage in Escherichia coli. J. Bacteriol. 2007, 189(5), 1616-1626. 
128. Mello-Filho, A. C.; Meneghini, R. Iron is the intracellular metal involved in the production 
of DNA damage by oxygen radicals. Mutat Res Fund Mol Mech Mut. 1991, 251(1), 109-
113. 
69 
 
129. Hoffmann, M. E.; Mello-Filho, A. C.; Meneghini, R. Correlation between cytotoxic effect of 
hydrogen peroxide and the yield of DNA strand breaks in cells of different species. Biochim. 
Biophys. Acta. 1984, 781(3), 234-238. 
130. Halliwell, B.;  Gutteridge, J. M. Role of free radicals and catalytic metal ions in human 
disease: An overview. Methods Enzymol. 1990, 186, 1–85. 
131. García, C. R.;  Angelé-Martínez, C.; Wilkes, J. A.; Wang, H. C.; Battin, E. E.; Brumaghim, 
J. L. Prevention of iron- and copper-mediated DNA damage by catecholamine and amino 
acid neurotransmitters, L-DOPA, and curcumin: metal binding as a general antioxidant 
mechanism. Dalton Trans. 2012, 41(21), 6458-6467 
 
 
70 
 
 (
M
il
li
on
s)
0
10
.0
20
.0
30
.0
40
.0
50
.0
X : parts per Million : 1H
12.0 11.0 10.0 9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0 -1.0 -2.0
   
6.
71
5
   
6.
69
5
   
6.
69
2
   
6.
64
3
   
6.
56
3
   
6.
53
2
   
6.
51
2
   
3.
71
2
   
3.
69
6
   
3.
69
2
   
3.
67
8
   
2.
68
6
   
2.
66
6
   
2.
64
9
   
2.
63
3
2.
07
2.
00
1.
04
1.
04
1.
00
APPENDICES  
Appendix A1: 1H NMR Spectrum for Compound 1 in CDCl3 and CD3OD 
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Appendix B1: 1H NMR Spectrum for Compound 3 in CDCl3 
 
 
 
 
 
 
 
 
 
 
 
 (
M
il
li
on
s)
0
10
.0
20
.0
30
.0
X : parts per Million : 1H
12.0 11.0 10.0 9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0 -1.0 -2.0
   
7.
87
3
   
7.
86
8
   
7.
85
2
   
7.
84
6
   
7.
78
8
   
7.
78
3
   
7.
31
4
   
7.
29
3
   
2.
58
4
   
2.
31
7
   
2.
31
3
6.
00
3.
09
1.
03
1.
02
1.
01
 (
M
il
li
on
s) 0
1.
0
2.
0
3.
0
4.
0
5.
0
6.
0
7.
0
8.
0
9.
0
X : parts per Million : 1H
8.8 8.7 8.6 8.5 8.4 8.3 8.2 8.1 8.0 7.9 7.8 7.7 7.6 7.5 7.4 7.3 7.2 7.1 7.0 6.9 6.8 6.7 6.6 6.5 6.4 6.3 6.2
   
7.
87
3
   
7.
86
8
   
7.
85
2
   
7.
84
6
   
7.
78
8
   
7.
78
3
   
7.
31
4
   
7.
29
3
6.
00
3.
09
1.
03
1.
02
1.
01
 (
M
il
li
o
n
s)
0
1
0
.0
2
0
.0
3
0
.0
X : parts per Million : 1H
3.0 2.9 2.8 2.7 2.6 2.5 2.4 2.3 2.2 2.1 2.0 1.9
  
 2
.5
8
4
  
 2
.3
1
7
  
 2
.3
1
3
6
.0
0
3
.0
9
1
.0
3
1
.0
2
1
.0
1
74 
 
 (
M
il
li
on
s)
-0
.1
0
0.
1
0.
2
0.
3
0.
4
0.
5
0.
6
0.
7
0.
8
0.
9
1.
0
1.
1
1.
2
1.
3
1.
4
1.
5
1.
6
1.
7
1.
8
1.
9
2.
0
X : parts per Million : 13C
220.0 210.0 200.0 190.0 180.0 170.0 160.0 150.0 140.0 130.0 120.0 110.0 100.0 90.0 80.0 70.0 60.0 50.0 40.0 30.0 20.0 10.0 0 -10.0 -20.0
 1
96
.0
83
 1
68
.2
02
 1
67
.8
43
 1
46
.1
03
 1
42
.3
10
 1
35
.6
80
 1
26
.9
86
 1
23
.8
12
 1
23
.7
74
 1
08
.9
62
  2
6.
68
9
  2
0.
80
1
  2
0.
70
2
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Appendix C1: 1H NMR Spectrum for Compound 4 in CDCl3 
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Appendix D: 1H NMR Spectrum for Compound 3 in CDCl3 and CD3OD 
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Appendix F: 1H NMR Spectrum for Compound 10 in CDCl3 
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Appendix G1: 1H NMR Spectrum for Compound 11 in CDCl3 
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Appendix H1: 1H NMR Spectrum for Compound 12 in CDCl3 
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Appendix I1: 1H NMR Spectrum for Compound 13 in CDCl3 
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Appendix J2: 1H NMR Spectrum for Compound 14 in CDCl3 
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Appendix J2: 13C NMR Spectrum for Compound 14 in CDCl3 
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Appendix K: 1H NMR Spectrum for Crude Compound 16 in CDCl3 
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Appendix L1: 1H NMR Spectrum for Compound 18 in CDCl3 
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Appendix L2: 13C NMR Spectrum for Compound 18 in CDCl3 
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Appendix M1: 1H NMR Spectrum for Compound 19 in CDCl3 
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Appendix M2: 13C NMR Spectrum for Compound 19 in CDCl3 
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